C-GLYCOSYL BOND CONFORMATION IN OXAZOFURIN - CRYSTALLOGRAPHIC AND COMPUTATIONAL STUDIES OF THE OXAZOLE ANALOG OF TIAZOFURIN

被引:34
作者
GOLDSTEIN, BM
LI, H
HALLOWS, WH
LANGS, DA
FRANCHETTI, P
CAPPELLACCI, L
GRIFANTINI, M
机构
[1] MED FDN BUFFALO INC, BUFFALO, NY 14203 USA
[2] UNIV CAMERINO, DIPARTIMENTO SCI CHIM, I-62032 CAMERINO, ITALY
关键词
D O I
10.1021/jm00037a019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Oxazofurin is the inactive oxazole analogue of the C-glycosyl thiazole antitumor agent tiazofurin. Replacement of the thiazole sulfur in tiazofurin with the oxazole oxygen in oxazofurin produces conformational effects that are examined using crystallographic and computational methods. The crystal structure of oxazofurin contains six molecules in the asymmetric unit and has been refined to a standard R value of 6.8% for all data. The six oxazofurin conformers show an average C-glycosidic torsion angle of 70(9)degrees. This value is significantly higher than the average absolute C-glycosidic torsion angle of 24(10)degrees obtained from previous thiazole nucleoside structures. Previous studies suggest that, in tiazofurin, an electrostatic interaction between a positively charged thiazole sulfur and negatively charged furanose oxygen constrains the C-glycosidic torsion angle to a relatively small value. Ab initio molecular orbital studies presented here suggest that the higher C-glycosidic angles observed in the oxazofurin structures result from a repulsive interaction between negatively charged oxazole and furanose oxygens. Thus, it is likely that differences in activity between oxazo- and tiazofurin are either (1) due directly to differences in electronic properties between the thiazole and oxazole rings or (2) due to the variation in C-glycosidic bond conformation resulting from the alteration in the charge distribution of the heterocycle.
引用
收藏
页码:1684 / 1688
页数:5
相关论文
共 37 条
[11]  
FRISCH MJ, 1988, BROWSE QUANTUM CHEM
[12]  
Glendening E. D, 1990, NBO 3 0 PROGRAM MANU
[13]   ARA-TIAZOFURIN - CONSERVATION OF STRUCTURAL FEATURES IN AN UNUSUAL THIAZOLE NUCLEOSIDE [J].
GOLDSTEIN, BM ;
MAO, DT ;
MARQUEZ, VE .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (05) :1026-1031
[14]  
GOLDSTEIN BM, 1991, BLOOD, V78, P593
[15]   STRUCTURAL STUDIES OF A NEW ANTI-TUMOR AGENT - TIAZOFURIN AND ITS INACTIVE ANALOGS [J].
GOLDSTEIN, BM ;
TAKUSAGAWA, F ;
BERMAN, HM ;
SRIVASTAVA, PC ;
ROBINS, RK .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1983, 105 (25) :7416-7422
[16]  
HEHRE WJ, 1986, AB INITIO MOL ORBITA, pCH4
[17]   CARBOXAMIDE GROUP CONFORMATION IN THE NICOTINAMIDE AND THIAZOLE-4-CARBOXAMIDE RINGS - IMPLICATIONS FOR ENZYME BINDING [J].
HONG, L ;
GOLDSTEIN, BM .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (19) :3560-3567
[18]   CLINICAL PHARMACOKINETIC STUDY OF TIAZOFURIN ADMINISTERED AS A 1-HOUR INFUSION [J].
JAYARAM, HN ;
LAPIS, E ;
TRICOT, G ;
KNEEBONE, P ;
PAULIK, E ;
ZHEN, WN ;
ENGELER, GP ;
HOFFMAN, R ;
WEBER, G .
INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (02) :182-188
[19]  
JAYARAM HN, 1982, BIOCHEM PHARMACOL, V31, P2371, DOI 10.1016/0006-2952(82)90532-9
[20]  
JAYARAM HN, UNPUB